Charles River Laboratories

Charles River Laboratories

Yahoo Finance • 11 days ago

Demand Stabilization Fuels Charles River Laboratories International’s (CRL) Recovery

Cooke & Bieler, an investment management firm, released its second-quarter investor letter for "Mid Cap Value Equity Strategy." The letter can be downloaded here. U.S. equities rallied significantly in Q2, driven by shifting geopolitical r... Full story

Yahoo Finance • 11 days ago

Computer-Aided Drug Discovery - Global Strategic Business Report: Capitalize on 11% CAGR as AI-led CADD surges from $3.2B in 2025 to $6.7B by 2032—benchmark Bayer, Charles River Laboratories, Pharmaron and Chemical Computing Group to secure growth.

Company Logo AI, machine learning, cloud analytics and multi-omics are accelerating drug discovery, enabling targeted, personalized therapies while reducing development time, cost and risk. Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE) -- "Com... Full story

Yahoo Finance • 16 days ago

Contract Research Organization Services Market Forecasts Growth from $107.03B (2025) to $180.56B by 2030, Profiling IQVIA, Charles River, Syneos Health & WuXi AppTec

Company Logo Opportunities center on AI-enabled decentralized trials, therapeutic specialization, global patient recruitment, regulatory support, real-world evidence and integrated partnerships. Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) --... Full story

Yahoo Finance • 16 days ago

Drug Safety Market Forecasts Growth from $7.12B (2026) to $10.21B by 2032, Profiling IQVIA, ICON, Charles River, Oracle & Parexel

Company Logo Opportunities include validated AI, cloud safety platforms, real-world evidence, integrated pharmacovigilance, patient-centric reporting and expansion in emerging markets. Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Drug Saf... Full story

Yahoo Finance • 17 days ago

Capitalize on Pharmacokinetics Outsourcing Disruption as Charles River, Labcorp, WuXi AppTec, Eurofins and Sygnature Compete to Dominate Drug Development ROI

Company Logo Demand for outsourced pharmacokinetics services is rising, driven by AI, advanced bioanalysis, personalized medicine, biologics and complex global trials. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Pharmacokinetics Services... Full story

Yahoo Finance • 17 days ago

3 Unpopular Stocks Walking a Fine Line

3 Unpopular Stocks Walking a Fine Line When Wall Street turns bearish on a stock, it's worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other busin... Full story

Yahoo Finance • 18 days ago

Capitalize on the In Vivo Toxicology Shake-Up: Benchmark Charles River, Labcorp, Evotec, WuXi AppTec and Thermo Fisher Before R&D Shifts Redraw Global Market Share

Company Logo Stricter safety rules, drug innovation and CRO outsourcing drive demand, while imaging, CRISPR and data analytics improve testing and reduce animal use. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "In Vivo Toxicology - Global... Full story

Yahoo Finance • 19 days ago

Capitalize on the ADME-Toxicology Testing Shift: Benchmark Charles River, Thermo Fisher, Eurofins, WuXi AppTec and Evotec to Accelerate R&D ROI and Outpace Disruption

Company Logo Demand is rising for faster, accurate ADME-Tox testing, driven by complex biologics, tighter regulation, personalized medicine, and adoption of high-throughput, in vitro and in silico methods. Dublin, Sept. 22, 2026 (GLOBE N... Full story

Yahoo Finance • 19 days ago

Here’s Why This Strategy Decided to Exit Charles River Laboratories (CRL)

Riverwater Partners, an investment management company, released its 'Sustainable Value Strategy' Q2 2026 investor letter. The letter can be downloaded here. Small-cap stocks achieved their best first-half performance since 1991, with the R... Full story

Yahoo Finance • 23 days ago

Charles River Laboratories International (CRL) Stock Fair Value Rises After Analysts Lift Targets

The analyst fair value estimate for Charles River Laboratories International has shifted from US$230.93 to US$282.43, a change of about 22% in the updated work. That move sits against Street commentary that now ranges from targets in the l... Full story

Yahoo Finance • 26 days ago

Beat the Market the Zacks Way: FIGS, Microsoft, Amphenol in Focus

Last Friday, the three benchmark stock indexes on Wall Street closed a losing week. The Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite slipped 1.6%, 0.8% and 0.7% respectively. The weekly decline was primarily due to a... Full story

Yahoo Finance • last month

Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks

[Health Care Medical Concept] ogichobanov/iStock via Getty Images The healthcare sector (XLV [https://seekingalpha.com/symbol/XLV]) gained 4.91% in August, outperforming the broader S&P 500 (SPY [https://seekingalpha.com/symbol/SPY]), whi... Full story

Yahoo Finance • 2 months ago

Unpacking Q2 Earnings: Repligen (NASDAQ:RGEN) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q2 Earnings: Repligen (NASDAQ:RGEN) In The Context Of Other Drug Development Inputs & Services Stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same s... Full story

Yahoo Finance • 2 months ago

1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges

1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion... Full story

Yahoo Finance • 2 months ago

Charles River Laboratories (CRL) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Todd Spencer Chief Executive Officer - Birgit Girshick Executive Vice President and Chief Financial Of... Full story

Yahoo Finance • 2 months ago

Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls

Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as c... Full story

Yahoo Finance • 2 months ago

Charles River (CRL) Is Up 11.0% After Raising Adjusted EPS Outlook Amid Divestiture-Driven GAAP Losses – Has The Bull Case Changed?

In August 2026, Charles River Laboratories International reported second-quarter revenue of US$1,004.08 million, swinging to a small net loss, and simultaneously cut its 2026 GAAP EPS guidance to US$3.05–US$3.35 per share, largely due to l... Full story

Yahoo Finance • 2 months ago

Stock Indices Fall from Early Highs and Settle Mixed

The S&P 500 Index ($SPX) (SPY) on Wednesday closed down -0.17%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.49%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.83%.  September E-mini S&P futures (ESU26) fell -0.19%,... Full story

Yahoo Finance • 2 months ago

Here are the major earnings before the open Wednesday

Major earnings expected before the bell on Wednesday include: * The Walt Disney Company (DIS [https://seekingalpha.com/symbol/DIS]) * Eli Lilly and Company (LLY [https://seekingalpha.com/symbol/LLY]) * Shopify (SHOP [https://seeking... Full story

Yahoo Finance • 3 months ago

In Vitro Toxicology Testing Market to Exceed $20.97 Billion by 2031 as Non-Animal Testing & AI Adoption Accelerate - Analysis by Product, Toxicity Endpoints & Type, Technology, Method, Service, Region

Company Logo Featuring Thermo Fisher Scientific, Agilent Technologies, Merck, Eurofins Scientific, Charles River Labs and Other Key Players In Vitro Toxicology Testing MarketIn Vitro Toxicology Testing Market Dublin, July 23, 2026 (GLOB... Full story